Monitoring Cerebral Blood Flow in Neurosurgical Intensive Care
Monitoring Cerebral Blood Flow in Neurosurgical Intensive Care
Therapeutic concepts in neurosurgical intensive care require sophisticated and refined neuromonitoring applications, because the individualised approach to the treatment of head-injured patients relies on the assessment and interpretation of the key parameters of brain tissue viability and function. Monitoring of regional cerebral blood flow (rCBF) in particular has been a long-term problem due to a lack of devices available for continuous bedside online monitoring. A novel thermal diffusion (TD) microprobe was introduced recently for continuous bedside monitoring of rCBF (TD-rCBF). The following article provides a description of the technique and describes the clinical application and the potential of this novel microprobe to assess CBF in patients suffering from subarachnoid haemorrhage (SAH) or traumatic brain injury (TBI)
In neurosurgical practice, monitoring of CBF plays an important role, as the brain depends on continuous blood supply due to its inability to store glucose or oxygen. During pathological conditions such as SAH or TBI, the patient – and consequently the functions of the brain – cannot be supervised clinically. Furthermore, secondary insults in SAH or TBI represent dangerous and often lethal complications, making continuous neuromonitoring essential for neurosurgical intensive care. Under these conditions, rCBF is considered an important upstream monitoring parameter that is indicative of tissue viability. In order to be able to establish new therapeutic approaches that focus on the pathophysiological basis of the secondary insult, neuromonitoring strategies need further refinement, as continuous monitoring of intracranial pressure (ICP) and cerebral perfusion pressure (CPP) has failed to adequately identify malperfusion in the brain-injured patient.1 In this scenario, continuous monitoring of rCBF could provide the opportunity to diagnose and to correct insufficient rCBF before deficits in tissue oxygenation and metabolism are recognised.2 There are a variety of CBF measurement techniques available, such as stable xenon-enhanced computed tomography (sXe-CT), single-photon-emission computed tomography (SPECT), magnetic resonance imaging (MRI) and positron emission tomography (PET); however, these methods are hampered by several clinical and practical drawbacks.
Monitoring of rCBF in neurosurgical intensive care should ideally be performed in a continuous way at the bedside, providing quantitative rCBF values with high temporal and spatial resolution. Although laser- Doppler flowmetry (LDF)- and thermal diffusion flowmetry (TDF)-based measurement techniques provide continuous bedside monitoring of CBF, their clinical acceptance has been very low due to enduring technical drawbacks. Since LDF detects and measures erythrocyte flux, definite conclusions about nutritive perfusion and quantitative CBF cannot be drawn by means of this method.3 Furthermore, TDF-based measurement techniques, such as cortically placed probes, were hampered by difficulties regarding the reliability and validity of the readings obtained.3 Recently, however, the TD-rCBF microprobe, which is implanted intra-parenchymally and therefore circumvents the major drawbacks of the old systems that have been in use so far, has been introduced in clinical practice. It enables the quantitative, continuous bedside assessment of rCBF, which guarantees high reliability due to advanced mathematical modelling systems.4 This article illustrates the technique of the TD-rCBF microprobe and introduces its clinical application in patients with SAH and TBI.
Intra-parenchymal Thermal Diffusion Flowmetry of Regional Cerebral Blood Flow
Thermal Diffusion Flowmetry – Probe Design
The TD-microprobe consists of a flexible, medical-grade polyurethane catheter of 0.9mm diameter with two thermistors (a proximal and a distal thermistor, 5mm apart) embedded within the catheter. The distal thermistor is heated to approximately 2°C above the tissue temperature, thereby generating a constant spherical temperature field with a diameter of approximately 4mm. By positioning the thermistors 5mm apart, the proximal thermosensor is located outside the thermal field, thereby allowing continuous monitoring of tissue temperature and compensation of baseline fluctuations. The power dissipated by the heated thermistor (0.005–0.01W) provides a direct measure of the tissue’s ability to transport heat. However, thermal transfer includes both intrinsic conductive properties of the tissue and convective effects induced by blood perfusion. Therefore, it is necessary to separate thermal conduction and convection components in order to achieve an adequate and reliable measurement of CBF in quantitative and absolute physiological data. This was usually achieved by no-flow calibration with earlier heated probes, making heated probes impractical for daily clinical use in neurosurgical intensive care. The TD-rCBF microprobe discussed in this article permits reliable quantification of tissue perfusion by determining the conductive properties of the tissue from the initial rate of propagation of the thermal field and by separating this component from the total heat transfer as the determinant of the thermal convection component. Using a series of data-reduction algorithms, convection and conduction components are acquired separately, making no-flow calibration unnecessary. The volume of the generated temperature field is approximately 27mm3 and therefore allows analysis of rCBF in this area. Usually, CBF values are recorded at a rate of 1Hz during clinical application. Illustrations of the TD-rCBF microprobe usage and technical settings are depicted in Figure 1.
- Cremer OL, van Dijk GW, van Wensen E, et al., Effect of intracranial pressure monitoring and targeted intensive care on functional outcome after severe head injury, Crit Care Med, 2005;33:2207–13.
- Vajkoczy P, Horn P, Thome C, et al., Regional cerebral blood flow monitoring in the diagnosis of delayed ischemia following aneurysmal subarachnoid hemorrhage, J Neurosurg, 2003;98: 1227–34.
- Schroder ML, Muizelaar JP, Monitoring of regional cerebral blood flow (CBF) in acute head injury by thermal diffusion, Acta Neurochir Suppl (Wien), 1993;59:47–9.
- Vajkoczy P, Roth H, Horn P, et al., Continuous monitoring of regional cerebral blood flow: experimental and clinical validation of a novel thermal diffusion microprobe, J Neurosurg, 2000;93:265–74.
- Qureshi AI, Sung GY, Razumovsky AY, et al., Early identification of patients at risk for symptomatic vasospasm after aneurysmal subarachnoid hemorrhage, Crit Care Med, 2000;28:984–90.
- Weir B, Grace M, Hansen J, et al., Time course of vasospasm in man, J Neurosurg, 1978;48:173–8.
- Charpentier C, Audibert G, Guillemin F, et al., Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage, Stroke, 1999;30: 1402–8.
- Kassell NF, Haley EC Jr., Apperson-Hansen C, et al., Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand, J Neurosurg, 1996;84:221–8.
- Kassell NF, Sasaki T, Colohan AR, et al., Cerebral vasospasm following aneurysmal subarachnoid hemorrhage, Stroke, 1985;16:562–72.
- Unterberg AW, Sakowitz OW, Sarrafzadeh AS, et al., Role of bedside microdialysis in the diagnosis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage, J Neurosurg, 2001;94:740–49.
- Clyde BL, Resnick DK, Yonas H, et al., The relationship of blood velocity as measured by transcranial doppler ultrasonography to cerebral blood flow as determined by stable xenon computed tomographic studies after aneurysmal subarachnoid hemorrhage, Neurosurgery, 1996;38:896–904; discussion 904–5.
- Powers WJ, Grubb RL Jr., Baker RP, et al., Regional cerebral blood flow and metabolism in reversible ischemia due to vasospasm. Determination by positron emission tomography, J Neurosurg, 1985;62:539–46.
- Munch E, Vajkoczy P, Current advances in the diagnosis of vasospasm, Neurol Res, 2006;28:703–12.
- Bouma GJ, Muizelaar JP, Choi SC, et al., Cerebral circulation and metabolism after severe traumatic brain injury: the elusive role of ischemia, J Neurosurg, 1991;75:685–93.
- Gopinath SP, Valadka AB, Uzura M, et al., Comparison of jugular venous oxygen saturation and brain tissue Po2 as monitors of cerebral ischemia after head injury, Crit Care Med, 1999;27:2337–45.
- Vespa P, Prins M, Ronne-Engstrom E, et al., Increase in extracellular glutamate caused by reduced cerebral perfusion pressure and seizures after human traumatic brain injury: a microdialysis study, J Neurosurg, 1998;89:971–82.
- Lassen NA, The luxury perfusion syndrome, Scand J Clin Lab Invest Suppl, 1968;102:X:A.
- Langfitt TW, Tannanbaum HM, Kassell NF, The etiology of acute brain swelling following experimental head injury, J Neurosurg, 1966;24:47–56.
- Chesnut RM, Marshall SB, Piek J, et al., Early and late systemic hypotension as a frequent and fundamental source of cerebral ischemia following severe brain injury in the Traumatic Coma Data Bank, Acta Neurochir Suppl (Wien), 1993;59:121–5.
- Robertson C, Desaturation episodes after severe head injury: influence on outcome, Acta Neurochir Suppl (Wien), 1993;59: 98–101.
- Robertson C, Measurements of cerebral blood flow and metabolism in severe head injury using the Kety-Schmidt technique, Acta Neurochir Suppl (Wien), 1993;59:25–7.
- Unterberg AW, Kiening KL, Hartl R, et al., Multimodal monitoring in patients with head injury: evaluation of the effects of treatment on cerebral oxygenation, J Trauma, 1997;42:S32–7.
